Claudio Agnorelli

Research Associate at the Centre for Psychedelic Research, Imperial College London

Data updated

Papers

5 publications

Trials

0 clinical trials

Research Footprint

Claudio Agnorelli appears in 5 tracked papers (2023–2026), most studied alongside Ketamine, DMT and LSD, across Neuroimaging & Brain Measures, Depressive Disorders and Healthy Volunteers.

Most-cited paper: Psychedelic therapy in the treatment of addiction: the past, present and future (93 citations).

Frequent co-authors: David Erritzoe, David Nutt and Andrea Fagiolini.

Background & Research

Claudio Agnorelli is a researcher affiliated with the Centre for Psychedelic Research at Imperial College London and the University of Siena. His recent work spans ketamine-induced neuroplasticity, psychedelic tryptamine membrane permeation, and broader reviews of psychedelics and neuroplasticity. He is listed as a Research Associate at Imperial College London and has published on both clinical and preclinical psychedelic topics.

Affiliations

Institutions, companies, and organisations Claudio Agnorelli is associated with.